Clal Insurance’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-396,771
Closed -$34.4M 82
2016
Q3
$34.4M Hold
396,771
0.78% 19
2016
Q2
$34.4M Hold
396,771
0.87% 29
2016
Q1
$29.9M Sell
396,771
-17
-0% -$1.28K 0.87% 31
2015
Q4
$30.6M Buy
396,788
+70,000
+21% +$5.27M 0.82% 36
2015
Q3
$22M Hold
326,788
0.57% 44
2015
Q2
$24.3M Buy
326,788
+307,288
+1,576% +$23.5M 0.56% 43
2015
Q1
$1.53M Buy
+19,500
New +$1.48M 0.04% 77

Other funds holding MDT

Clal Insurance's MDT Position: Q4 2016 in Review

Clal Insurance sold out of Medtronic (MDT) in Q4 2016, closing a stake of 396,771 shares — an estimated $34.4M sold.

Clal Insurance first reported a position in MDT in Q1 2015 and held it in 7 quarters. The position peaked at $34.4M in Q2 2016. 1,269 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • Clal Insurance reported no remaining Medtronic position as of Q4 2016 after selling out during the quarter.
  • Clal Insurance sold 396,771 Medtronic shares in Q4 2016, an estimated $34.4M.
  • Clal Insurance first reported a position in Medtronic in Q1 2015 and held it in 7 quarters.
  • Clal Insurance's Medtronic position peaked at $34.4M in Q2 2016.
  • 1,269 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on Clal Insurance's 13F filing for Q4 2016, filed 14 Feb 2017.